Clinical Trial Update: Treatment of Failing Blebs With Ranibizumab [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating ranibizumab for treatment of failing blebs after trabeculectomy in open-angle glaucoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: The New York Eye & Ear Infirmary | Conditions: Glaucoma, Open-Angle, Failing Bleb Following Trabeculectomy | Phase 1 | Status: COMPLETED